Kestrel Therapeutics Inc.

Biotechnology company · Boston, Massachusetts, United States

Kestrel Therapeutics Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Kestrel Therapeutics at a glance

Typebiotechnology company

HeadquartersBoston, Massachusetts, United States

Earliest incorporation on record2020

SEC CIK1853373

What does Kestrel Therapeutics do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $5 million sold (2025).

Frequently asked questions about Kestrel Therapeutics

Where is Kestrel Therapeutics headquartered?

Kestrel Therapeutics Inc. is headquartered in Boston, Massachusetts, United States.

What does Kestrel Therapeutics do?

Kestrel Therapeutics Inc. is a biotechnology company.

When was Kestrel Therapeutics founded?

The earliest incorporation on record for Kestrel Therapeutics Inc. is in 2020, according to public company registers.

Similar companies

Syntis Bio, Inc.Boston, Massachusetts, United States
Strand Therapeutics Inc.Boston, Massachusetts, United States
Pear Therapeutics, Inc.Boston, Massachusetts, United States
Aura Biosciences, Inc.Boston, Massachusetts, United States
Holobiome, Inc.Boston, Massachusetts, United States
Leuko Labs, Inc.Boston, Massachusetts, United States
Compass Therapeutics, Inc.Boston, Massachusetts, United States
Odyssey Therapeutics, Inc.Boston, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences